Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma

被引:96
作者
Ben, Qi-Wen [1 ]
Wang, Jian-Cheng [2 ]
Liu, Jun [1 ]
Zhu, Ying [1 ]
Yuan, Fei [3 ]
Yao, Wei-Yan [1 ]
Yuan, Yao-Zong [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pathol, Shanghai, Peoples R China
关键词
CELL-ADHESION MOLECULE; LONG-TERM SURVIVAL; CANCER CELLS; L1; EXPRESSION; METASTASIS; CARCINOMA; GENE; PROGRESSION; INHIBITION; ACTIVATION;
D O I
10.1245/s10434-010-0955-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal adenocarcinoma (PDAC) frequently invades and migrates along neural tissue, which results in local tumor recurrences, distant metastases, and poor prognosis. We evaluated whether L1 cell adhesion molecule (L1-CAM) and glial cell line-derived neurotrophic factor (GDNF) expression in PDAC correlated with neural invasion and overall survival on a large cohort of previously untreated patients. L1-CAM and GDNF were examined by immunohistochemistry in pancreatic cancer tissue samples of 94 cases with PDAC on a tissue microarray. The molecular findings were correlated with pain, clinicopathologic characteristics, and overall survival in these patients. L1-CAM and GDNF were overexpressed in pancreatic cancer tissues compared with the adjacent normal tissues of pancreas. Positive L1-CAM expression was associated with node involvement (P = 0.007), vascular invasion (P = 0.012), perineural invasion (P = 0.001), and higher degree of pain (P = 0.005). In univariate analysis, tissue expression of L1-CAM was associated with poor survival (hazard ratio, 2.508; 95% confidence interval, 1.551-4.053; P < 0.001), and this was also significant in multivariate analysis (hazard ratio, 2.046; 95% confidence interval, 1.200-3.488; P = 0.009). Positive staining of GDNF, neural invasion, and vascular invasion were all statistically significantly related to unfavorable prognosis. Enhanced expression of L1-CAM may contribute to the pain syndrome and perineural invasion and may correlate with poor overall survival in human pancreatic cancer.
引用
收藏
页码:2213 / 2221
页数:9
相关论文
共 49 条
[1]  
Allory Y, 2005, CLIN CANCER RES, V11, P1190
[2]   EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast [J].
Bachmann, IM ;
Halvorsen, OJ ;
Collett, K ;
Stefansson, IM ;
Straume, O ;
Haukaas, SA ;
Salvesen, HB ;
Otte, AP ;
Akslen, LA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) :268-273
[3]   Curative resection for left-sided pancreatic malignancy [J].
Bergenfeldt, Magnus ;
Moesgaard, Flemming ;
Burcharth, Flemming .
HPB, 2006, 8 (03) :211-215
[4]   INTERACTION OF PANCREATIC DUCTAL CARCINOMA WITH NERVES LEADS TO NERVE DAMAGE [J].
BOCKMAN, DE ;
BUCHLER, M ;
BEGER, HG .
GASTROENTEROLOGY, 1994, 107 (01) :219-230
[5]   The neurotrophic factor artemin promotes pancreatic cancer invasion [J].
Ceyhan, Guralp O. ;
Giese, Nathalia A. ;
Erkan, Mort ;
Kerscher, Annika G. ;
Wente, Moritz N. ;
Giese, Thomas ;
Büchler, Markus W. ;
Friess, Helmut .
ANNALS OF SURGERY, 2006, 244 (02) :274-281
[6]   NEURITE OUTGROWTH PROMOTING ACTIVITY OF G4 AND ITS INHIBITION BY MONOCLONAL-ANTIBODIES [J].
CHANG, S ;
RATHJEN, FG ;
RAPER, JA .
JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 25 (02) :180-186
[7]   Disruption of the mouse L1 gene leads to malformations of the nervous system [J].
Dahme, M ;
Bartsch, U ;
Martini, R ;
Anliker, B ;
Schachner, M ;
Mantei, N .
NATURE GENETICS, 1997, 17 (03) :346-349
[8]   L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas [J].
Fogel, M ;
Gutwein, P ;
Mechtersheimer, S ;
Riedle, S ;
Stoeck, A ;
Smirnov, A ;
Edler, L ;
Ben-Arie, A ;
Huszar, M ;
Altevogt, P .
LANCET, 2003, 362 (9387) :869-875
[9]   L 1 adhesion molecule (CD 171) in development and progression of human malignant melanoma [J].
Fogel, M ;
Mechtersheimer, S ;
Huszar, M ;
Smirnov, A ;
Abu-Dahi, A ;
Tilgen, W ;
Reichrath, J ;
Georg, T ;
Altevogt, P ;
Gutwein, P .
CANCER LETTERS, 2003, 189 (02) :237-247
[10]  
FRANSEN E, 1995, EUR J HUM GENET, V3, P273